自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

  • <tfoot id="icskm"></tfoot>
  • <code id="icskm"><xmp id="icskm"></xmp></code>
  • <li id="icskm"><input id="icskm"></input></li>
    <code id="icskm"></code>
  • <cite id="icskm"><center id="icskm"></center></cite><button id="icskm"><bdo id="icskm"></bdo></button><code id="icskm"></code>
  • <cite id="icskm"><pre id="icskm"></pre></cite>
    <button id="icskm"></button>
  • <rt id="icskm"><pre id="icskm"></pre></rt>
    <cite id="icskm"></cite>
    <li id="icskm"></li>
    <button id="icskm"><input id="icskm"></input></button>
  • 159-2642-3062 027-65317797
    服務熱線(工作日:9:00-17:30)

    瀏覽量: 485

    • 產品名稱: Doxorubicin
    • 產品貨號: CS00143
    • 貨期: 現(xiàn)貨
    • 價格與訂購: 308
    • 數量:
      庫存: 10
    • 規(guī)格: 10mg
    • 產品信息
    • 如何訂購
      產品描述
      Doxorubicin is a Topoisomerase II (Top2) inhibitor with antineoplastic activity. 
      靶點活性
      Topo II 
      體外活性
       Combination of Doxorubicin and Simvastatin in the highest tested concentrations (2 μM and 10 μM, respec-tively) kills 97% of the Hela cells[2]. 
      體內活性
       Mice bearing PC3 xenografts are injected with 2, 4 or 8 mg/kg Doxorubicin and tumor volume is measured over time. A dose of 2 mg/kg does not affect tumor growth while higher dosages delay tumor growth initially (p<0.05 at days 18 and 22), 4 mg/kg or 8 mg/kg Doxorubicin significantly reduces levels of c-FLIP in PC3 xenografts[3]. A single intraperitoneal injection 10 mg/kg (Doxorubicin 1) is administered in rats, 10 daily intraperitoneal injections of 1 mg/kg (Doxorubicin 2), or in 5 weekly intraperitoneal injections of 2 mg/kg (Doxorubicin 3). An 80% mortality rate is observed at day 28 in Doxorubicin 1, whereas Doxorubicin 2 and Doxorubicin 3 reached 80% mortality at days 107 and 98, respectively. Fractional shortening decreased by 30% at week 2 in Doxorubicin DOX1, 55% at week 13 in Doxorubicin 2, and 42% at week 13 in Doxorubicin 3[4]. 
      細胞實驗
      Doxorubicin is dissolved in stock solutions (1 mM) and serially diluted with RPMI 1640 media (0.1, 1, and 2 μM)[2]. 160 μL of Hela cells suspension (3×104 cell/mL) is dispensed into three 96-well U-bottom microplates and incubated for 24 h at 37°C in a fully humidified atmosphere of 5% CO2. In plate 1, serial dilutions of Doxorubicin (20 μL; final concentration, 0.1-2 μM) and Simvastatin (20 μL; final concentration, 0.25-2 μM) are added to a final volume of 200 μL and incubated for another 72 h. In plates 2 and 3 serial dilutions of each drug (Simvastatin or Doxorubicin, 40 μL) are added. After an incubation period of 24 h, the medium is aspirated and the cells are washed in PBS. Then, serial dilutions of other drug (40 μL) are added and supplemented with culture medium to a final volume of 200 μL, and incubated for 48 h. Doxorubicin and Simvastatin are used individually as positive controls (40 μL in each well), and the .
      別名
      阿霉素
      純度
      98%
      分子量
      543.52
      分子式
      C27H29NO11 
      CAS No.
      23214-92-8
      存儲
      Powder: -20°C for 3 years
      In solvent: -80°C for 2 years
      溶解度
      DMSO: 10 mM
      ( < 1 mg/ml refers to the product slightly soluble or insoluble )
      參考文獻
      1. Nitiss JL, et al. Targeting DNA topoisomerase II in cancer chemotherapy.Nat Rev Cancer. 2009 May;9(5):338-50.
      2. Sadeghi-Aliabadi H, et al. Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells. Res Pharm Sci. 2010 Jul;5(2):127-33.
      3. El-Zawahry A, et al. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancerxenografts. BMC Cancer. 2005 Jan 7;5:2.
      4. Hayward R, et al. Doxorubicin cardiotoxicity in the rat: an in vivo characterization. J Am Assoc Lab Anim Sci. 2007 Jul;46(4):20-32.
      5. Liang L, Tu Y, Lu J, et al. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting Wnt/β-catenin signaling pathway[J]. J Cell Sci. 2019 May 16;132(10).
      Note
      For research use only .
    威信县| 阿尔山市| 铜鼓县| 电白县| 宁波市| 双桥区| 南川市| 如皋市| 开鲁县| 专栏| 福泉市| 文登市| 邹平县| 察哈| 康保县| 双柏县| 日土县| 望谟县| 明溪县| 永顺县| 灌云县| 南川市| 浦东新区| 凤庆县| 堆龙德庆县| 隆子县| 中宁县| 和田县| 闽侯县| 三台县| 芜湖县| 新邵县| 宜黄县| 高邑县| 富顺县| 蛟河市| 新宁县| 南漳县| 金寨县| 新民市| 分宜县|